Health Care & Life Sciences » Biotechnology | Spotlight Innovation Inc.

Spotlight Innovation Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
-
-
-
-
2.20
Cost of Goods Sold (COGS) incl. D&A
1.40
0.50
3.00
4.70
131.60
Gross Income
1.40
0.50
3.00
4.70
129.40
SG&A Expense
5,165.10
1,486.10
4,904.40
6,665.20
4,501.30
EBIT
5,166.60
1,486.60
4,907.40
6,669.90
4,630.70
Unusual Expense
856.40
120.10
1,863.40
1,023.10
781.00
Non Operating Income/Expense
-
42.10
63.00
18.90
54.20
Interest Expense
787.30
2,060.60
1,379.50
9,198.10
1,136.10
Pretax Income
6,810.20
3,625.30
8,087.20
16,872.10
6,493.60
Consolidated Net Income
6,810.20
3,625.30
8,087.20
16,872.10
6,493.60
Net Income
6,810.20
3,623.50
8,041.70
16,779.10
6,169.90
Net Income After Extraordinaries
6,810.20
3,623.50
8,041.70
16,832.20
6,169.90
Net Income Available to Common
6,810.20
3,623.50
8,041.70
16,955.10
6,169.90
EPS (Basic)
0.96
0.28
0.58
0.93
0.19
Basic Shares Outstanding
7,100.90
13,006.70
13,973.30
18,020.60
32,233.90
EPS (Diluted)
0.96
0.28
0.58
0.93
0.19
Diluted Shares Outstanding
7,100.90
13,006.70
13,973.30
18,020.60
32,233.90
EBITDA
5,165.20
1,486.10
4,904.40
6,665.20
4,625.80
Minority Interest Expense
-
1.80
45.50
93.00
323.80

About Spotlight Innovation

View Profile
Address
11147 Aurora Avenue
Urbandale Iowa 50322
United States
Employees -
Website http://www.spotlightinnovation.com
Updated 07/08/2019
Spotlight Innovation, Inc. is a bioscience company, which engages in acquiring the rights and license to proprietary technologies. It operate through its subsidiaries, which identifies and targets technology candidates including cancer drugs and treatment therapies for disease states, and drug and treatment therapies for infectious diseases. The company was founded on December 12, 2013 and is headquartered in Urbandale, IA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.